Abstract
Postherpetic neuralgia (PHN) is dermatomal distribution pain that persists for months to years after the resolution of herpes zoster rash. The cause of PHN is unknown. Herein, we report clinical, molecular virological, and immunological findings over an 11-year period in an immunocompetent elderly woman with PHN. Initially, blood mononuclear cells (MNCs) contained varicellazoster virus (VZV) DNA on two consecutive occasions. Random testing after treatment with famciclovir to relieve pain did not detect VZV DNA. However, the patient was reluctant to continue famciclovir indefinitely and voluntarily stopped drug treatment five times. Pain always recurred within 1 week, and blood MNCs contained many, but not all, regions of the VZV genome on all five occasions. Immunological analysis revealed increased cell-mediated immunity to VZV. Chronic VZV ganglionitis—induced PHN best explains the recurrence of VZV DNA in MNCs whenever famciclovir was discontinued; the detection of only some regions of the viral genome in MNCs, compared to the detection of all regions of the VZV genome in latently infected ganglia; the increased cell-mediated immunity to VZV; and a gratifying clinical response to famciclovir. The presence of fragments of VZV DNA in MNCs likely represents partial degradation of viral DNA in MNCs that trafficked through ganglia during productive infection.
Similar content being viewed by others
References
Brown GR (1995). Herpes zoster: correlation of age, sex, distribution, neuralgia and associated disorders. South Med J 69: 576–578.
Devlin ME, Gilden DH, Mahalingam R, Dueland AN, Cohrs R (1992). Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA. J Infect Dis 165: 619–622.
Feldman S, Chaudary S, Ossi M, Epp E (1977). A viremic phase for herpes zoster in children with cancer. J Pediatr 91: 597–600.
Forghani B (1986). Varicella-zoster virus antibody. In: Methods of enzymatic analysis, Vol. 10, 3rd ed. Bergmeyer H (ed). Weinheim: Verlag Chemic, pp 267–284.
Furuta Y, Ohtani F, Mesuda Y, Fukuda S, Inuyama Y (2000). Early diagnosis of zoster sine herpete and antiviral therapy for the treatment of facial palsy. Neurology 55: 708–710.
Gilden DH, Devlin M, Wellish M, Mahalingam R, Huff C, Hayward A, Vafai A (1988). Persistence of varicella-zoster virus DNA in blood MNCs of patients with varicella or zoster. Virus Genes 2: 299–305.
Gilden DH, Hayward AR, Krupp J, Hunter-Laszlo M, Huff JC, Vafai A (1987). Varicella-zoster virus infection of human mononuclear cells. Virus Res 7: 117–129.
Gilden DH, Wright RR, Schneck SA, Gwaltney JM Jr, Mahalingam R (1994). Zoster sine herpete, a clinical variant. Ann Neurol 35: 530–533.
Hayward A, Levin M, Wolf W, Gilden DH (1991). Varicella zoster virus specific immunity following herpes zoster. J Infect Dis 163: 873–875.
Hayward AR, Zerbe GO, Levin MJ (1994). Clinical application of responder cell frequency estimates with four years of follow up. J Immunol Methods 170: 27–36.
Hiroshige K, Ikeda M, Hondo R (2002). Detection of varicella zoster virus DNA in tear fluid and saliva of patients with Ramsay Hunt syndrome. Otol Neurotol 23: 602–607.
Hope-Simpson RE (1965). The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58: 9–20.
Mahalingam R, Wellish M, Brucklier J, Gilden DH (1995). Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neuro Virol 1: 130–133.
Mahalingam R, Wellish M, Wolf W, Dueland AN, Cohrs R, Vafai A, Gilden DH (1990). Latent varicella zoster virus DNA in human trigeminal and thoracic ganglia. N Engl J Med 323: 627–631.
Mahalingam R, Wellish MC, Dueland AN, Cohrs RJ, Gilden DH (1992). Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia. Ann Neurol 31: 444–448.
Mainka C, Fuss B, Geiger H, Hofelmayr H, Wolff MH (1998). Characterization of viremia at different stages of varicella-zoster virus infection. J Med Virol 56: 91–98.
Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N (1996). Bell’s palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 124: 27–30.
Schunemann S, Mainka C, Wolff MH (1999). No acute varicella-zoster virus replication in peripheral blood mononuclear cells during postherpetic neuralgia. Acta Virol 43: 337–340.
Sweeney CJ, Gilden DH (2001). Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry 71: 149–154.
Terada K, Niizuma T, Kawano S, Kataoka N, Akisada T, Orita Y (1998). Detection of varicella-zoster virus DNA in peripheral mononuclear cells from patients with Ramsay Hunt syndrome or zoster sine herpete. J Med Virol 56: 359–363.
Thomas SL, Wheeler JG, Hall AJ (2002). Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 360: 678–682.
Vafai A, Wellish M, Gilden DH (1988). Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia. Proc Natl Acad Sci U S A 85: 2767–2770.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported in part by Public Health Service grants NS 32623 and AG 06127 from the National Institutes of Health.
Rights and permissions
About this article
Cite this article
Gilden, D.H., Cohrs, R.J., Hayward, A.R. et al. Chronic varicella-zoster virus ganglionitis—a possible cause of postherpetic neuralgia. Journal of NeuroVirology 9, 404–407 (2003). https://doi.org/10.1080/13550280390201722
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280390201722